ADVM - Adverum Biotechnologies, Inc.
4.36
0.100 2.294%
Share volume: 1,023,039
Last Updated: 12-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$4.26
0.10
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-04-2024 | 05-14-2025 | 08-12-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 1.000 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 1.000 M | 0.000 | 0.000 | 0.000 | |
| nan% | inf% | -100.00% | nan% | nan% | |||
| Operating expenses | 26.839 M | 20.882 M | 30.221 M | 48.221 M | 49.855 M | 48.023 M | |
| Selling general and admin | 11.429 M | 3.785 M | 9.782 M | 19.474 M | 12.730 M | 9.110 M | |
| Research and development | 15.410 M | 17.097 M | 20.439 M | 28.747 M | 37.125 M | 38.913 M | |
| Total expenses | 26.839 M | 20.882 M | 30.221 M | 48.221 M | 49.855 M | 48.023 M | |
| -22.20% | 44.72% | 59.56% | 3.39% | -3.67% | |||
| Operating income | -26.839 M | -20.882 M | -29.221 M | -48.221 M | -49.855 M | -48.023 M | |
| Ebit | -24.828 M | -18.478 M | -26.893 M | -47.072 M | -49.202 M | -47.652 M | |
| Pretax income | -24.787 M | -18.476 M | -27.134 M | -47.072 M | -49.202 M | -47.652 M | |
| -25.46% | 46.86% | 73.48% | 4.52% | -3.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -24.787 M | -18.476 M | -27.134 M | -47.019 M | -49.191 M | -47.652 M | |
| 25.46% | -46.86% | -73.28% | -4.62% | 3.13% |